• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

byNeel MistryandTeddy Guo
November 15, 2022
in Cardiology, Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability compared to less intensive targets.

2. Major intracerebral hemorrhage and all-cause mortality were comparable between groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Management of systolic blood pressure (sBP) post-endovascular thrombectomy is critical for preventing complications following acute ischemic strokes. However, this must be done with caution as a significant drop in sBP may compromise tissue perfusion. The optimal sBP target in patients following endovascular thrombectomy remains unclear. This randomized trial aimed to compare the safety and efficacy of different blood pressure targets in patients with elevated systolic blood pressure post-endovascular thrombectomy. The primary outcome was functional recovery at 90 days, as defined by the modified Rankin scale (range 0-6, 0 = no symptoms, 6 = death) while key secondary outcomes included death or neurological deterioration at day 7. According to study results, more intensive BP management (sBP <120 mmHg) may compromise functional recovery and should be avoided in patients with recent endovascular thrombectomy. The more intensive BP target group was more likely to have neurologic deterioration and major disabilities compared to the less intensive group. However, major cerebral hemorrhage was comparable between study groups. This study was strengthened by a large sample size with patients from multiple hospitals in China, thus increasing its validity.

Click to read the study in The Lancet

Relevant Reading: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension

RELATED REPORTS

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study

2 Minute Medicine Rewind November 3rd, 2025

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

In-depth [randomized-controlled trial]: Between July 20, 2020, and March 7, 2022, 1828 patients were screened for eligibility at 44 tertiary care centers in China. Included were ≥ 18 years old who had undergone endovascular thrombectomy for acute ischemic stroke and had a sustained elevated systolic blood pressure (≥140 mmHg for <10 mins). Altogether, 799 patients (398 to more intensive treatment group and 401 to less intensive treatment group) were included in the per-protocol analysis. The primary outcome of poor functional outcome at 90 days post-thrombectomy was greater in the more intensive group than in the less intensive blood pressure control group (odds ratio [OR] 1.37, 95% confidence interval [CI] 1.07-1.76). Similarly, a greater proportion of patients in the more intensive group had neurological deterioration at seven days (OR 1.53, 95% CI 1.18-1.97) and major disability at three months (OR 2.07, 95% CI 1.47-2.93). Symptomatic intracerebral hemorrhage (6% each) and all-cause mortality (16% in more intensive group vs. 15% in less intensive group) were comparable. Overall, findings from this study suggest that less intensive therapy (sBP <140-180 mmHg) is preferred in patients with elevated sBP post-endovascular thrombectomy.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute ischemic strokeblood pressureblood pressure controlBlood pressure targetsischemic strokepost-stroke reperfusionstroke
Previous Post

Low vitamin D is associated with increased risk of all-cause mortality

Next Post

Comparable outcomes amongst three different types of drug-eluting stents in BIO-RESORT Trial

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study

November 7, 2025
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind November 3rd, 2025

November 3, 2025
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Emergency

Code stroke of large vessel occlusion at triage improves candidate selection and workflow efficiency of endovascular thrombectomy

October 28, 2025
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Comparable outcomes amongst three different types of drug-eluting stents in BIO-RESORT Trial

#VisualAbstract: Renal artery denervation is effective and well-tolerated for blood pressure reduction

#VisualAbstract: Renal artery denervation is effective and well-tolerated for blood pressure reduction

Combined immunotherapy may improve survival in metastatic pancreatic cancer

Triple mRNA vaccination and previous COVID-19 exposure provide protection against the omicron variant

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis
  • Bisphosphonates may reduce short-term pain in complex regional pain syndrome 
  • Reducing saturated fat decreases mortality in high-risk individuals
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.